TCL 019 (Papaverine Hydrochloride SR 150 mg)
Pill with imprint TCL 019 is Brown, Capsule-shape and has been identified as Papaverine Hydrochloride SR 150 mg. It is supplied by UDL Laboratories Inc.
Papaverine is used in the treatment of vasospasm and belongs to the drug class peripheral vasodilators. FDA has not classified the drug for risk during pregnancy. Papaverine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TCL 019
More about papaverine
- Papaverine Side Effects
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- Drug class: peripheral vasodilators
- FDA Alerts (2)
- Papaverine Hydrochloride (AHFS Monograph)
- Papaverine Hydrochloride Injection (FDA)
- Papaverine (Wolters Kluwer)
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.